EverPoint Asset Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$23.9M Buy
1,260,000
+660,000
+110% +$12.5M 0.44% 40
2016
Q3
$13.4M Buy
600,000
+50,000
+9% +$1.12M 0.24% 90
2016
Q2
$9.8M Buy
+550,000
New +$9.8M 0.19% 120
2015
Q4
Sell
-175,000
Closed -$3.55M 490
2015
Q3
$3.55M Buy
175,000
+60,000
+52% +$1.22M 0.09% 239
2015
Q2
$3.81M Buy
+115,000
New +$3.81M 0.07% 282
2014
Q3
Sell
-100,000
Closed -$1.17M 485
2014
Q2
$1.17M Buy
+100,000
New +$1.17M 0.02% 387